Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Omicron Variant of COVID-19”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Early research (Phase 1)Study completedNCT05972993
What this trial is testing

A Safety and Immune Response Study to Evaluate Varying Doses of an mRNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Healthy Adults

Who this might be right for
COVID-19
GlaxoSmithKline 114
Post-approval studies (Phase 4)Study completedNCT06208540
What this trial is testing

Clinical Characteristics and Treatment of Anosmia and Ageusia Due to SARS-CoV2 Variants

Who this might be right for
Post-covid-19 Persistent Smell and Taste Disorders
Sherifa Ahmed Hamed 160
Early research (Phase 1)Not Yet RecruitingNCT07791186
What this trial is testing

Safety, Tolerability, and Immunogenicity of BMI2012 Against COVID-19 Variant in Healthy Adults Aged 19 and 55 Years

Who this might be right for
Prevention of COVID-19 Variant (Omicron JN.1)
BMI Korea 72
Early research (Phase 1)Study completedNCT05923424
What this trial is testing

A Trial to Learn if Different Doses of REGN17092 Are Safe in Healthy Adults

Who this might be right for
Healthy Volunteers
Regeneron Pharmaceuticals 40
Testing effectiveness (Phase 2)Study completedNCT05652543
What this trial is testing

A PhaseⅡ Study to Evaluate the Safety & Immunogenicity of SARS-CoV-2 Alpha/Beta/Delta/Omicron Variants COVID-19 Vaccine

Who this might be right for
COVID-19 Pandemic
Sinocelltech Ltd. 518
Testing effectiveness (Phase 2)UnknownNCT05522829
What this trial is testing

Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine SCTV01E-1 in Population Aged Above 18 Years

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 400
Testing effectiveness (Phase 2)UnknownNCT05933512
What this trial is testing

Evaluate the Immunogenicity and Safety of A Recombinant Protein COVID-19 Vaccine as Booster Vaccines

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 600
Large-scale testing (Phase 3)Study completedNCT05372588
What this trial is testing

Phase 3 Boosting Study for the SARS-CoV-2 rS Variant Vaccines

Who this might be right for
COVID-19SARS CoV 2 Infection
Novavax 1,340
Not applicableUnknownNCT05778318
What this trial is testing

Efficacy of Lianhua Qingwen in Treating Patients Infected With the Omicron Variant of the COVID-19

Who this might be right for
COVID-19 Pneumonia
Qianfoshan Hospital 200
Large-scale testing (Phase 3)UnknownNCT05683561
What this trial is testing

A Phase III Clinical Trial to Evaluate the Efficacy and Safety of SCTV01E in Healthy People

Who this might be right for
COVID-19 SARS-CoV-2 Infection
Sinocelltech Ltd. 6,000
Testing effectiveness (Phase 2)WithdrawnNCT05308602
What this trial is testing

Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E (Two Recombinant Protein COVID-19 Vaccines) in Population Aged ≥12 Years

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd.
Testing effectiveness (Phase 2)UnknownNCT05329051
What this trial is testing

Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine in Population Aged ≥18 Years

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
Sinocelltech Ltd. 400
Testing effectiveness (Phase 2)Study completedNCT05383560
What this trial is testing

Safety and Immunogenicity of Omicron Variant-Matched Vaccine Booster in Adults

Who this might be right for
COVID-19 PandemicImmunogenicitySARS CoV 2 Infection+1 more
Sheba Medical Center 179
Not applicableStudy completedNCT06170307
What this trial is testing

Left Atrial Function of COVID-19-recovered Patients During the Surge of Omicron Variants

Who this might be right for
COVID-19 Pandemic
Haiyan Wang 150
Not applicableUnknownNCT05379543
What this trial is testing

Echocardiographic Manifestation in Patients With Omicron Variant of COVID-19

Who this might be right for
COVID-19
RenJi Hospital 200
Large-scale testing (Phase 3)UnknownNCT05636319
What this trial is testing

Evaluate the Efficacy, Safety, and Immunogenicity of SARS-CoV-2 Variant (BA.4 /5) mRNA Vaccine

Who this might be right for
COVID-19
Suzhou Abogen Biosciences Co., Ltd. 14,168
Early research (Phase 1)UnknownNCT05434585
What this trial is testing

Evaluate Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19) mRNA Vaccines

Who this might be right for
COVID-19
Suzhou Abogen Biosciences Co., Ltd. 60
Testing effectiveness (Phase 2)UnknownNCT05930730
What this trial is testing

Immunogenicity and Safety of Comvigen (Bivalent) Vaccine

Who this might be right for
Safety of a Single Dose of COMVIGEN VaccineReactogenicity of a Single Dose of COMVIGEN VaccineImmunogenicity of a Single Dose of COMVIGEN Vaccine+3 more
Chulalongkorn University 450
Early research (Phase 1)UnknownNCT05433194
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19 Omicron) mRNA Vaccine (Phase 1)

Who this might be right for
COVID-19
Suzhou Abogen Biosciences Co., Ltd. 48
Testing effectiveness (Phase 2)UnknownNCT05345873
What this trial is testing

Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine as a Booster Dose in Population Aged 12-17 Years

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 300
Next Page